Nath Bio-Genes (India) (NATHBIOGEN) — Annual Report

📢 Key Event
Nath Bio-Genes proposes ₹2/share dividend, re-appoints Satish Kagliwal as MD, and outlines FY27 growth outlook.

🔄 What Changed
Revenue grew 19% YoY to ₹4,316 million; EBITDA margin stable at 12%; dividend declared at ₹2/share; MD remuneration increased from ₹66 lakh to ₹1.44 crore; FY27 revenue growth forecast of 15-20%.

🔮 What's Next
FY27 revenue growth expected at 15-20%, with cotton and paddy driving gains; international operations to remain below 15% of revenue; asset-light strategy continues; R&D investment sustained.

💡 Investor Takeaway
Shareholders benefit from a proposed dividend increase and stable profitability, but face near-term risks from monsoon variability and regulatory changes affecting GM seed commercialization.

Nath Bio-Genes (India) Ltd reported FY26 revenue of ₹4,316 million (19% YoY growth) with EBITDA margin at 12% and PAT of [amount context mismatch] million, driven by strong cotton and paddy sales. The Board proposed a dividend of ₹2 per share (20% payout) and re-appointed Managing Director Satish Kagliwal with remuneration revised to ₹1.44 crore annually. Key risks include monsoon uncertainty, regulatory tightening on GM seeds, and margin pressure from lower-margin vegetable seeds. The company maintains an asset-light strategy, R&D focus, and international expansion in Uzbekistan, with FY27 revenue growth projected at 15-20%.

📄 View Original Announcement (PDF)

📊 Stock Analysis — NATHBIOGEN ✨ Ask AI About This

About Nath Bio-Genes (India) Ltd (NATHBIOGEN)

Fast Moving Consumer Goods · FMCG · Listed on BSE

Market Cap: ₹289.43 Cr P/E: 7.8 ROE: 6.0% ROCE: 7.9% Div Yield: 1.31%

View full NATHBIOGEN stock details →

📡 Get AI alerts when NATHBIOGEN files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track NATHBIOGEN — Free

💡 Ask AI about this filing

"How will monsoon variability impact FY27 cotton and paddy revenue growth targets?" "What is the expected timeline for regulatory approval of GM seed applications in India?" "How will the company mitigate margin pressure from increased vegetable seed sales?"

Ask AI Free →

📊 More NATHBIOGEN filings

See all NATHBIOGEN filings →

🔥 Also filed on 1 September 2026

WHBRADY W H Brady & Co Ltd Annual Report SUDARSCHEM Sudarshan Chemical Industries Ltd Announcement 544083 Shree Marutinandan Tubes Ltd Annual Report SHERVANI Shervani Industrial Syndicate Ltd Corporate Action CORDSCABLE Cords Cable Industries Ltd Annual Report FORTIS Fortis Healthcare Ltd Announcement

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when NATHBIOGEN files new disclosures

Track NATHBIOGEN filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track NATHBIOGEN — Free

Free account · 2 AI queries/day

About · Privacy Policy · Terms of Service · Pricing

Today's Announcements · Screener · Insights · AI Chat

Data provided by CMOTS Internet Technologies Pvt Ltd